View PDF Edition - U.S. Pharmacist

U.S. PharmacistWhat’s NewsEditorial Board of AdvisorsJoseph Bova, RPhCommunity Pharmacy Owner,Cary’s Pharmacy,Dobbs Ferry, New York;Member, NYS Board of PharmacyCarmen Catizone, RPhExecutive Director, National Associationof Boards of PharmacyJohn M. Coster, PhD, RPhSenior VP of Government AffairsNational Community Pharmacists Assoc.Hewitt (Ted) W. Matthews, PhDDean, Southern School of Pharmacy,Mercer University, AtlantaDavid G. Miller, RPhPharmacy Affairs, Merck & Co., Inc.,West Point, PennsylvaniaMario F. Sylvestri, PharmD, PhDSenior Director, Medical Science Liaisons,Amylin PharmaceuticalsRay A. Wolf, PharmDMedical Education, Sanofi AventisMary Ann E. Zagaria,PharmD, MS, CGPSenior Care Consultant andPresident, MZ Associates, Inc.,Norwich, New YorkContributing EditorsLoyd V. Allen, Jr., PhDConnie Barnes, PharmDBruce Berger, PhDR. Keith Campbell, RPh, CDEPatrick N. Catania, PhD, RPhR. Rebecca Couris, PhD, RPhEd DeSimone, PhD, RPhRonald W. Maddox, PharmDSomnath Pal, BS (Pharm), MBA, PhDW. Steven Pray, PhD, DPhM. Saljoughian, PharmD, PhDJesse C. Vivian, BS Pharm, JDSend your comments viaEDITOR@USPHARMACIST.COMMail: 160 Chubb Avenue, Suite 306Lyndhurst, NJ 07071Telephone: (201) 623-0999Editorial Dept. Fax: (201) 623-0991Internet: www.uspharmacist.comFDA Approves Gardasil for Genital Warts in Men and BoysSilver Spring, MD — The FDA approved the vaccine Gardasil for theprevention of genital warts resulting from the human papillomavirus (HPV)types 6 and 11 in boys and men age 9 through 26 years. A randomized trial of4,055 males age 16 through 26 showed that Gardasil was 90% effective inpreventing genital warts, and studies measuring the immune response of malesage 9 through 15 were equally positive. Each year, about two out of every1,000 men in the United States are diagnosed with genital warts. Gardasilcurrently is approved for use in girls and women age 9 through 26 for theprevention of cervical, vulvar, and vaginal cancer caused by HPV types 16 and18; precancerous lesions caused by types 6, 11, 16, and 18; and genital wartscaused by types 6 and 11. Most genital warts are caused by HPV infection,which is the most common sexually transmitted infection in the U.S.IMS Predicts 4% to 6% Global Pharma Market Growth Next YearNorwalk, CT — IMS Health reported that the value of the globalpharmaceutical market in 2010 is expected to grow 4% to 6% on aconstant-dollar basis, exceeding $825 billion. The forecast predicts globalpharmaceutical market sales to grow at a 4% to 7% compound annual ratethrough 2013, and considers the impact of the global macroeconomy, thechanging mix of innovative and mature products, and the rising influence ofhealth care access and funding on market demand. The value of the globalpharmaceutical market is expected to expand to $975+ billion by 2013.“Overall, market growth is expected to remain at historically low levels, butstronger-than-expected demand in the U.S. is lifting both our short- andlong-term forecasts,” said Murray Aitken, senior vice president, HealthcareInsight, IMS Health.FDA Warns About Illegal H1N1 Vaccines on the WebSilver Spring, MD — The FDA warned consumers about purchasing anyproducts over the Internet that claim to diagnose, prevent, treat, or cure theH1N1 influenza virus. The warning comes after the FDA recently purchasedand analyzed several products represented online as Tamiflu (oseltamivir) thatmay pose risks to patients. One of the orders, which arrived in an unmarkedenvelope with a postmark from India, consisted of unlabeled white tabletstaped between two pieces of paper. When analyzed by the FDA, the tabletswere found to contain talc and acetaminophen, but none of the activeingredient oseltamivir. The Web site disappeared shortly after the FDA placedthe order.Smoking Bans Reduce Heart Attack RiskWashington, DC — A report from the Institute of Medicine says thatsmoking bans are effective at reducing the risk of heart attacks and heartdisease associated with secondhand smoke. The report also provides evidencethat breathing secondhand smoke boosts the risk for heart problems innonsmokers, adding that there is evidence that relatively brief exposures couldlead to a heart attack. About 43% of nonsmoking children and 37% ofnonsmoking adults are exposed to secondhand smoke in the U.S., accordingto public health data.5U.S. Pharmacist • November 2009 • www.uspharmacist.com